Eli Lilly’s CEO David Ricks could sign more deals to strengthen its pipeline of cancer drugs, but is leaving gene cell-based CAR-T oncology drugs and rare disease gene therapies for others to ...

Eli Lilly and Co. joined several other investors in a Series A round for a Boston biotech co-founded by the Longwood Fund that's developing a drug for a rare type of blood cancer.

As part of the deal, Boston, the Massachusetts-based firm will receive ... clinically meaningful therapeutic responses in patients. "Lilly's commitment to innovation and deep expertise in bringing ...

Personal: Daughter of Stacey Rios and Christopher Ferguson … Has three siblings, Rory, Skylan and Mariah Verdi on Ferguson: "Lilly will bring some depth and strength to the wing position. Offensively, ...